Drug Markets/Ulipristal Acetate

Ulipristal Acetate

1 NDC across 1 manufacturer|0 Generic,1 Brand

▸ More about this market

The brand product was first FDA-approved on Aug 13, 2010, and the first generic was approved Feb 13, 2017. FDA's Orange Book lists 2 AB-rated (therapeutically equivalent) products for this ingredient.

Ulipristal Acetate is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $37.10 to $37.10 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$37.10 – $37.10

per EA

7d Activity

1↓0 flat

avg -0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing ULIPRISTAL ACETATE

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
ELLA 30 MG TABLET
$37.0980
per EA
-0.01%

Frequently Asked Questions

When did Ulipristal Acetate become available as a generic?

FDA approved the first generic Ulipristal Acetate (ANDA) on Feb 13, 2017. The Orange Book currently lists 2 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How many Ulipristal Acetate products are on the market?

The Ulipristal Acetate drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Ulipristal Acetate?

NADAC reference prices for Ulipristal Acetate range from $37.0980 to $37.0980 per EA.

Which manufacturers make Ulipristal Acetate?

1 manufacturer lists Ulipristal Acetate in NADAC. Ranked by number of NDCs, the largest are HRA PHARMA AMERICA, INC. (1).

How has the price of Ulipristal Acetate changed recently?

Over the past 7 days, 0 Ulipristal Acetate NDCs rose and 1 fell, with a market-wide average change of -0.0%.